Combined effect of p53-armed oncolytic virus and immune checkpoint inhibitors in murine pancreatic cancer models

被引：0
|
作者：
Fujita, Shuto [1 ]
Tazawa, Hiroshi [1 ,2 ]
Kajiwara, Yoshinori [1 ]
Kikuchi, Satoru [1 ]
Kuroda, Shinji [1 ]
Noma, Kazuhiro [1 ]
Urata, Yasuo [3 ]
Kagawa, Shunsuke [1 ]
Fujiwara, Toshiyoshi [1 ]
机构：
[1] Okayama Univ, Grad Sch Med, Dept Surg Gastroenterol, Okayama, Japan
[2] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan
[3] Oncolys BioPharma Inc, Tokyo, Japan
来源：
CANCER SCIENCE | 2025年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2182
引用
收藏
页码：961 / 961
页数：1
相关论文
共 46 条
  • [41] Prognostic effect of coexisting TP53 and ZFHX3 mutations in non-small cell lung cancer patients treated with immune checkpoint inhibitors
    Zhang, Lijuan
    Zhang, Tongyan
    Shang, Bin
    Li, Yaqiong
    Cao, Zhixin
    Wang, Hui
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2021, 94 (03)
  • [42] Efficacy and safety of immune checkpoint inhibitors combined with chemotherapy as first-line treatment for extensive-stage small cell lung cancer: a meta-analysis based on mixed-effect models
    Zheng, Jianqing
    Deng, Yujie
    Huang, Bifen
    Chen, Xiaohui
    FRONTIERS IN MEDICINE, 2023, 10
  • [43] Recombinant Newcastle disease viruses expressing immunological checkpoint inhibitors induce a pro-inflammatory state and enhance tumor-specific immune responses in two murine models of cancer
    Santry, Lisa A.
    van Vloten, Jacob P.
    AuYeung, Amanda W. K.
    Mould, Robert C.
    Yates, Jacob G. E.
    McAusland, Thomas M.
    Petrik, James J.
    Major, Pierre P.
    Bridle, Byram W.
    Wootton, Sarah K.
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [44] Association of Tumor Protein p53 and Ataxia-Telangiectasia Mutated Comutation With Response to Immune Checkpoint Inhibitors and Mortality in Patients With Non-Small Cell Lung Cancer
    Chen, Yu
    Chen, Gang
    Li, Jin
    Huang, Ying-Ying
    Li, Yi
    Lin, Jing
    Chen, Li-Zhu
    Lu, Jian-Ping
    Wang, Yu-Qi
    Wang, Chang-Xi
    Pan, Leong Kin
    Xia, Xue-Feng
    Yi, Xin
    Chen, Chuan-Ben
    Zheng, Xiong-Wei
    Guo, Zeng-Qing
    Pan, Jian-Ji
    JAMA NETWORK OPEN, 2019, 2 (09) : E1911895
  • [45] Clinical Efficacy of Antianlotinib Combined with Immune Checkpoint Inhibitors in the Treatment of Advanced Non-Small-Cell Lung Cancer and Its Effect on Serum VEGF, CEA, and SCC-Ag
    He, Linghui
    Chen, Xi
    Ding, Lingchi
    Zhang, Xuedong
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [46] mTOR inhibitor, gemcitabine and PD-L1 antibody blockade combination therapy suppresses pancreatic cancer progression via metabolic reprogramming and immune microenvironment remodeling in Trp53flox/+LSL-KrasG12D/+Pdx-1-Cre murine models
    Qiu, Jiangdong
    Feng, Mengyu
    Yang, Gang
    Cao, Zhe
    Liu, Yueze
    You, Lei
    Zhang, Taiping
    CANCER LETTERS, 2023, 554
12345